期刊文献+

可塞风与曲马多病人自控静脉镇痛的比较

Effect of Xafon on Analgesia During PCIA Compared with Tramadol in Patients Underwent Larynx Cancer Operations
原文传递
导出
摘要 目的:评价可塞风与曲马多自控静脉镇痛的镇痛效果及不良反应。方法:40例ASAⅠ-Ⅱ级喉癌根治术患者,随机分为L(可塞风)组和T(曲马多)组,手术缝合时,L组静注可塞风8mg,T组静注曲马多100mg,手术结束前5分钟经外周静脉连接自控式镇痛泵。输注模式:背景量2ml/h,追加量0.5ml,锁定时间15min。药液配制:L组:可塞风48mg加生理盐水至120ml;T组:曲马多1000mg加生理盐水至120ml。镇痛期间观察视觉模拟评分(VAS)、舒适评分(BCS)及不良反应。结果:两组比较VAS与BCS均无统计学差异。曲马多组恶心、呕吐、出汗等反应高于可塞风。结论:可塞风与曲马多都能提供良好的术后镇痛。可塞风伴有较少的不良反应,在临床上更值得应用和推广。 Objective: To evaluate the efficacy of xafon and tramadol on patient-controlled intravenous analgesia (PCIA) in patients underwent larynx cancer operations. Methods: 40 patients (ASA I- Ⅱ) larynx cancer operations under general anesthesia were randomly allocated to either group L or gruop T with 20 cases each.At the time of wound closure,xafon was administered intravenously at a dose kf 8mg(group L), tramadol was administered intravenously at a dose of 100 mg (group T). The analgesic prescription included xafon 48rag diluted with Ns to 120ml(group L),tramadol 1000rag diluted with Ns to 120ml(group T),and continuous infused at a rate of 2ml/h, bolus dose was 0.5ml and lock-out interval 15rain. To observe the visual analgesia score (VAS), Bruggrmann comfort score(BCS) and adverse events during the analgesia. Results: There was no statistical difference in VAS and BCS (P〉0.05). Group T was higher than group L in nausea, vomitus and diaphoresis,et al. Conclusion: Group L can provide the same analgesic efficacy as group T. Postoperative analgesia with xafon is more worthy of application in clinic associated with a lower incidence of adverse events.
出处 《中国伤残医学》 2007年第3期27-28,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 可塞风 曲马多 喉癌 镇痛 Xafon Tramadol Larynx cancer Analgesia
  • 相关文献

参考文献2

二级参考文献14

  • 1Tsai YC,Won SJ, Lin MT. Effects of morphine on immune response in rats with sciatic constriction injury.Pain, 2000,88 : 155-160.
  • 2Rosenow DE, Albrechtsen M, Stolke D. A comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery.Anesth Analg, 1998,86:1045-1050.
  • 3Page GG,Blakely WP,Ben-Eliyahu S,et al. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain,2001,90 : 191-199.
  • 4Helmy SA, Wahby MA, EI-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production.Anaesthesia , 1999 ,54 :733-738.
  • 5Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clin Pharmacokinet,1998,34: 421-428.
  • 6Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J,1990,66(Suppl 4) : 18-21.
  • 7Kehlet H,Werner M, Perkins F. Balanced analgesia. Whatis it and what are its advantages in postoperative pain?Drugs, 1999,58 : 793-797.
  • 8McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain, 1994,59 : 6-43.
  • 9Kullich W,Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam on the secretion of the endogenos opiatc peptides dynorphin and β-endorphin. Aktuel Rheumatol, 1992,17 : 128-132.
  • 10Code W. NASIDs and balanced analgesia. Can J Anaesth, 1993,40 : 401-405.

共引文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部